KEMPHARM, INC·4

May 18, 5:25 PM ET

Pascoe Richard W 4

4 · KEMPHARM, INC · Filed May 18, 2022

Insider Transaction Report

Form 4
Period: 2022-05-18
Transactions
  • Purchase

    Common Stock

    2022-05-18$4.90/sh+300$1,4703,585 total
  • Purchase

    Common Stock

    2022-05-18$4.90/sh+100$4903,685 total
  • Purchase

    Common Stock

    2022-05-18$4.91/sh+400$1,9644,085 total
  • Purchase

    Common Stock

    2022-05-18$4.91/sh+400$1,9644,485 total
  • Purchase

    Common Stock

    2022-05-18$4.93/sh+1,700$8,3817,952 total
  • Purchase

    Common Stock

    2022-05-18$4.92/sh+1,767$8,6946,252 total
  • Purchase

    Common Stock

    2022-05-18$4.94/sh+333$1,6458,285 total

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4